Tetraneuron

About:

Tetraneuron is a drug discovery company in treating brain and neurodegenerative conditions.

Top Investors: Région Sud Investissement, Valencia Institute of Finance

Description:

Tetraneuron is a gene therapy biotech company. They develop disruptive multifactorial gene therapy to treat Alzheimer’s disease and a biomarker for early detection of this disease. They respond to customer inquiries by contact form and email.

Total Funding Amount:

8.5M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Valencia, Comunidad Valenciana, Spain

Founded Date:

2012-01-01

Contact Email:

info(AT)tetraneuron.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-12-27

IPO Status:

Private

Industries: